MX1 and myeloid sarcoma: NMO patients who were partially treated with low-dose steroids or plaquenil have normal levels of serum type I IFN activity (6× greater than in MS), and in vitro induction of P-Y-STAT-1, MxA, and viperin is excessive compared to healthy controls (Figure 3).